List of Excipients in API FLURBIPROFEN SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing FLURBIPROFEN SODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | CITRIC ACID MONOHYDRATE | |
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | EDETATE DISODIUM | |
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | HYDROCHLORIC ACID | |
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | POLYVINYL ALCOHOL | |
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | POTASSIUM CHLORIDE | |
| Rebel Distributors Corp | FLURBIPROFEN SODIUM | flurbiprofen sodium | 42254-023 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing FLURBIPROFEN SODIUM
Detailed excipient profiles for FLURBIPROFEN SODIUM
Excipient focus: CITRIC ACID
FLURBIPROFEN SODIUM drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | flurbiprofen sodium | 21695-615 |
| >Company | >Ingredient | >NDC |
FLURBIPROFEN SODIUM drug variants not containing CITRIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
FLURBIPROFEN SODIUM drug variants containing CITRIC ACID MONOHYDRATE
FLURBIPROFEN SODIUM drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | flurbiprofen sodium | 21695-615 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
FLURBIPROFEN SODIUM drug variants containing EDETATE DISODIUM
FLURBIPROFEN SODIUM drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
FLURBIPROFEN SODIUM drug variants containing HYDROCHLORIC ACID
FLURBIPROFEN SODIUM drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
FLURBIPROFEN SODIUM drug variants containing POLYVINYL ALCOHOL
FLURBIPROFEN SODIUM drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
FLURBIPROFEN SODIUM drug variants containing POTASSIUM CHLORIDE
FLURBIPROFEN SODIUM drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
FLURBIPROFEN SODIUM drug variants containing SODIUM CHLORIDE
FLURBIPROFEN SODIUM drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
FLURBIPROFEN SODIUM drug variants containing SODIUM CITRATE
FLURBIPROFEN SODIUM drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
FLURBIPROFEN SODIUM drug variants containing SODIUM HYDROXIDE
FLURBIPROFEN SODIUM drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THIMEROSAL
FLURBIPROFEN SODIUM drug variants containing THIMEROSAL
FLURBIPROFEN SODIUM drug variants not containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
FLURBIPROFEN SODIUM drug variants containing WATER
FLURBIPROFEN SODIUM drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch